Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C.
about
Role of occult hepatitis B virus infection in chronic hepatitis COccult hepatitis B virus infectionUpdate on occult hepatitis B virus infectionOccult hepatitis B virus and hepatocellular carcinomaProcesses to manage analyses and publications in a phase III multicenter randomized clinical trialVirus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.A Practical Model Evaluating Antiviral Cytokines by Natural Killer Cells in Treatment Naïve Patients with Chronic Hepatitis B Virus Infection.Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma.Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell LymphomaImpact of antibody to hepatitis B core antigen on the clinical course of hepatitis C virus carriers in a hyperendemic area in Japan: A community-based cohort study.Past exposure to hepatitis B: a risk factor for increase in mortality?Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.The prevalence and long term outcome of occult hepatitis B virus infections in community based populations.Clinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis.Molecular mechanisms underlying HBsAg negativity in occult HBV infection.Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitroThe oncologic burden of hepatitis C virus infection: A clinical perspective.Associations of Antibody to Hepatitis B Core Antigen-positivity with Outcomes in Hepatocellular Carcinoma Patients Undergoing Hepatic Resection.Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis.Occult hepatitis B virus infection: bit player or role player?Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma.Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.
P2860
Q26823538-CF3DC0CD-1811-4CF6-938E-FD8D7D9BED2EQ27004224-B1279D15-4055-4B73-804E-3A04AA960ED9Q28070317-0925C5C7-67EA-4545-88EB-33F6234DC338Q33661018-4B9751FB-5B33-4315-8FC0-B8DD18307D8FQ33694159-876BAE10-F47B-40C2-BAFC-A475EF8A5B91Q33723810-CB49339B-5DD4-4745-AA7D-9B4CDDA7055FQ33919051-0BB150CD-1DD1-40A7-A4E6-FCD75529A79AQ34785204-76DB45C6-4498-40D7-8E2D-52B0E7C0D7F2Q36522482-91F44042-A529-408C-92E3-F19987515EF8Q37009627-F49DDBBE-45ED-4D5C-AA7E-1A65ADDC7B5BQ37228545-B8F364EC-6028-4F96-AA40-11266BF015B3Q37281965-8DFABD33-F1B6-47EA-80BE-493724AB02AFQ37411514-AEDCEFAF-7108-461E-ABE6-697F35F8BA03Q37641840-16521B66-794C-4CD1-AF3E-6204432AEC9BQ38028865-7F005A90-C235-4D3B-AE28-0A3BF5F18476Q38125450-E6A3604A-ECC6-4DDF-BB40-769147B133B5Q38536404-AA167872-9D2B-4C5E-BE84-560BF4D16607Q39281237-14E2C5B9-884F-4245-BE79-E685984F6CBAQ39418450-C59916EA-E8F9-4765-AC47-C5976A24EC2BQ40121871-CCE74BF3-F15E-4A09-BBEB-2347129FDBB1Q40595308-9446DEE7-5AB5-4842-8C2A-4442E4B52446Q45365162-1E78CD92-B14C-4FAC-AC4B-A49BB8D69A98Q47559332-018120B3-FBC9-49E9-8201-DD4407E631CAQ54249544-1C9280C6-C9FC-45BB-AA20-1D2C7C01A316
P2860
Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Occult and previous hepatitis ...... ents with chronic hepatitis C.
@ast
Occult and previous hepatitis ...... ents with chronic hepatitis C.
@en
type
label
Occult and previous hepatitis ...... ents with chronic hepatitis C.
@ast
Occult and previous hepatitis ...... ents with chronic hepatitis C.
@en
prefLabel
Occult and previous hepatitis ...... ents with chronic hepatitis C.
@ast
Occult and previous hepatitis ...... ents with chronic hepatitis C.
@en
P2093
P2860
P356
P1433
P1476
Occult and previous hepatitis ...... ents with chronic hepatitis C.
@en
P2093
Anna S Lok
HALT-C Trial Group
Hae-Young Kim
James E Everhart
Munira Hussain
Timothy R Morgan
P2860
P304
P356
10.1002/HEP.24257
P407
P577
2011-08-01T00:00:00Z